Fundraising FoxSolas BioVentures — 2019 Investments
1 investments dated 2019 · listed companies and verified rows first · show all
CardioNXTcardionxt.comMar 2019
CardioNXT develops cardiac mapping and navigation technology, including its iMap System, used to navigate next-generation pulsed field ablation (PFA) catheters for cardiac procedures such as pulmonary vein isolation and left atrium mapping.
HardwareHealthtechMedical DevicesWestminster, US
Donald Conty(Executive Officer, Director, Promoter)Jerome Edwards(Executive Officer, Director, Promoter)
BoardThomas Kurian(Director, Promoter)
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.